IMARC Group's report titled "Antisense & RNAi Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on the global antisense & RNAi therapeutics market report. The global market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to...

The global RNA Therapeutics Market is on the verge of a transformative period, poised to revolutionize the field of healthcare with innovative RNA-based therapies. MnM, a leading player in the biopharmaceutical industry, is at the forefront of this groundbreaking advancement, committed to providing cutting-edge RNA therapeutics to enhance patient care and outcomes. The RNA therapeutics market...

Owing to their vast potential in controlling disease-associated gene expression, RNAi therapeutics have emerged as a key segment of the market; several big pharma players have undertaken RNAi focused initiatives.   In addition to effective gene silencing, these candidates can be deployed for applications related to precision medicine. Studies have also demonstrated the safety of RNAi...